Report into J&J recalls looms

[at Financial Times] - An internal report into the manufacturing problems over the past year that ...

[$$] Follow-Up

[at Barrons.com] - Sanofi Aventis offers $69 a share in cash for Genzyme. Could the money be better ...

History Predicts Genzyme Will Sell For $80 Per Share

[at Minyanville] - A historical analysis of unsolicited bids shows that there's a high likelihood ...

Wisconsin pharmacist accused of selling fake drugs

[AP] - Federal prosecutors have accused a prominent Madison pharmacist and a Middleton man of ...

Journal editors criticise Abbott drug

Editors of the New England Journal of Medicine have suggested that the US Food and Drug ...

Allergan in $600m Botox settlement

Allergan has agreed to pay $600m as part of a settlement over the company's US marketing practices ...

Increased risk of death linked with Tygacil

The US FDA has issued a safety warning to remind healthcare professionals of the increased ...